Apyx Medical Corporation (APYX)
NASDAQ: APYX · Real-Time Price · USD
3.228
-0.012 (-0.38%)
Nov 5, 2025, 9:51 AM EST - Market open
Apyx Medical Market Cap
Apyx Medical has a market cap or net worth of $122.07 million as of November 5, 2025. Its market cap has increased by 197.71% in one year.
Market Cap
122.07M
Enterprise Value
132.31M
1-Year Change
197.71%
Ranking
Category
Stock Price
$3.23
Market Cap Chart
Since May 1, 1992, Apyx Medical's market cap has increased from $2.73M to $122.07M, an increase of 4,372.32%. That is a compound annual growth rate of 12.00%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 4, 2025 | 122.54M | 106.02% |
| Dec 31, 2024 | 59.48M | -34.47% |
| Dec 29, 2023 | 90.77M | 12.11% |
| Dec 30, 2022 | 80.96M | -81.61% |
| Dec 31, 2021 | 440.29M | 78.41% |
| Dec 31, 2020 | 246.78M | -14.63% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 811.99B |
| Johnson & Johnson | 450.20B |
| AbbVie | 381.38B |
| UnitedHealth Group | 299.68B |
| AstraZeneca | 253.45B |
| Novartis AG | 240.68B |
| Abbott Laboratories | 218.75B |
| Novo Nordisk | 215.64B |